Overview
DecisionRx, Inc. provides pharmacogenomic testing services that analyze how patients metabolize medications based on their genetic profiles to optimize drug selection and dosing. The company enables healthcare providers to make personalized treatment decisions that improve medication efficacy and reduce adverse drug reactions.
More in Genetic Testing
Latest industry news
Genomic Sovereignty in MENA: How the Region Is Building Its Own Precision Medicine Foundation
2026-10-12 · Industry
Vietnam's Gene Solutions Eyes Hong Kong IPO to Fund Southeast Asian Genomics Expansion
2026-10-11 · Industry
NeoGenomics FDA-Approved PTEN Test Raises the Question: Is the Stock Undervalued?
2026-10-10 · Product
Current Genetic Testing in Cancer May Miss Most Inherited Gene Variants, Study Warns
2026-10-09 · Research
Company details
Is this your company?
Claim this listing to add your logo, full description, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach genomics professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →